Categories
- Global News Feed
- Uncategorized
- Alabama Stem Cells
- Alaska Stem Cells
- Arkansas Stem Cells
- Arizona Stem Cells
- California Stem Cells
- Colorado Stem Cells
- Connecticut Stem Cells
- Delaware Stem Cells
- Florida Stem Cells
- Georgia Stem Cells
- Hawaii Stem Cells
- Idaho Stem Cells
- Illinois Stem Cells
- Indiana Stem Cells
- Iowa Stem Cells
- Kansas Stem Cells
- Kentucky Stem Cells
- Louisiana Stem Cells
- Maine Stem Cells
- Maryland Stem Cells
- Massachusetts Stem Cells
- Michigan Stem Cells
- Minnesota Stem Cells
- Mississippi Stem Cells
- Missouri Stem Cells
- Montana Stem Cells
- Nebraska Stem Cells
- New Hampshire Stem Cells
- New Jersey Stem Cells
- New Mexico Stem Cells
- New York Stem Cells
- Nevada Stem Cells
- North Carolina Stem Cells
- North Dakota Stem Cells
- Oklahoma Stem Cells
- Ohio Stem Cells
- Oregon Stem Cells
- Pennsylvania Stem Cells
- Rhode Island Stem Cells
- South Carolina Stem Cells
- South Dakota Stem Cells
- Tennessee Stem Cells
- Texas Stem Cells
- Utah Stem Cells
- Vermont Stem Cells
- Virginia Stem Cells
- Washington Stem Cells
- West Virginia Stem Cells
- Wisconsin Stem Cells
- Wyoming Stem Cells
- Biotechnology
- Cell Medicine
- Cell Therapy
- Diabetes
- Epigenetics
- Gene therapy
- Genetics
- Genetic Engineering
- Genetic medicine
- HCG Diet
- Hormone Replacement Therapy
- Human Genetics
- Integrative Medicine
- Molecular Genetics
- Molecular Medicine
- Nano medicine
- Preventative Medicine
- Regenerative Medicine
- Stem Cells
- Stell Cell Genetics
- Stem Cell Research
- Stem Cell Treatments
- Stem Cell Therapy
- Stem Cell Videos
- Testosterone Replacement Therapy
- Testosterone Shots
- Transhumanism
- Transhumanist
Archives
Recommended Sites
Category Archives: Stem Cell Therapy
First dog on Oahu gets stem cell therapy – Video
Posted: June 21, 2013 at 7:45 am
First dog on Oahu gets stem cell therapy
A 13-year-old dog who was barely able to walk is back on his paws thanks to stem cell therapy. Before the treatment Kumba suffered from arthritis so bad he c...
By: Joem Costes
Read the rest here:
First dog on Oahu gets stem cell therapy - Video
Posted in Cell Therapy, Stem Cell Therapy
Comments Off on First dog on Oahu gets stem cell therapy – Video
Pay-For-Eggs Legislation Draws More Media Attention
Posted: June 20, 2013 at 7:15 pm
California legislation to allow women
to be paid for their eggs for scientific research generated several news articles this week as the measure neared final legislative
approval.
to be paid for their eggs for scientific research generated several news articles this week as the measure neared final legislative
approval.
The coverage included both pro and con
but did not amount to major attention from the mainstream media. And,
with one exception, the articles failed to report that the
legislation did not apply to research funded by the $3 billion
California stem cell agency, which bans compensation for egg
providers.
but did not amount to major attention from the mainstream media. And,
with one exception, the articles failed to report that the
legislation did not apply to research funded by the $3 billion
California stem cell agency, which bans compensation for egg
providers.
The proposal (AB926) is now on the
state Senate floor with a vote possibly coming as early as next
Thursday. A spokesman for the American Society for Reproductive
Medicine in Birmingham, Ala., an industry group sponsoring the bill,
said unequivocally that the Gov. Jerry Brown is expected to sign the
measure. (See the Senate floor bill analysis here and a press release on the bill here.)
state Senate floor with a vote possibly coming as early as next
Thursday. A spokesman for the American Society for Reproductive
Medicine in Birmingham, Ala., an industry group sponsoring the bill,
said unequivocally that the Gov. Jerry Brown is expected to sign the
measure. (See the Senate floor bill analysis here and a press release on the bill here.)
Assemblywoman Susan Bonilla Photo Source -- Bonilla's office |
The articles about the legislation by
Assemblywoman Susan Bonilla, D-Concord, have appeared in the journal
Nature, the San Francisco Chronicle and the Huffington Post over the
past few days.
Assemblywoman Susan Bonilla, D-Concord, have appeared in the journal
Nature, the San Francisco Chronicle and the Huffington Post over the
past few days.
Alice Crisci, a California patient
advocate writing on the Huffington Post, yesterday remarked that
women egg providers should be treated the same as men involved in
scientific experiments.
advocate writing on the Huffington Post, yesterday remarked that
women egg providers should be treated the same as men involved in
scientific experiments.
“After all, aren't we past the days
when we treat women like they are less capable than men of making
sound decisions for their own well-being? It's my body and my choice
if I want to donate a dozen of my eggs to science. Who knows -- maybe
it's my egg that will be used to find a cure for cancer.”
Debra Saunders, writing a column in the
Chronicle on Sunday, said,
Chronicle on Sunday, said,
“That sperm-egg parity argument is so
bogus. When men donate sperm, they risk second thoughts about
unknown, random offspring, but they do not risk serious medical side
effects. Egg donation, on the other hand, can be hazardous to your
health. The New York Times reports, "Egg donors can suffer
serious side effects from the powerful hormones needed to generate
multiple eggs." And: "The most significant risk is ovarian
hyper-stimulation syndrome, which can cause bloating, abdominal pain
and, rarely, blood clots, kidney failure and other life-threatening
ailments."
Charlotte Schubert, writing in Nature
on Tuesday, said,
on Tuesday, said,
“In practical terms, the bill would
bump up payments from hundreds to thousands of dollars. In Oregon —
which, like most states, does not have regulations governing egg
donation — women recently received $3,000–7,000 each for eggs
used in a study that created stem-cell
lines from cloned human embryos.”
Prices for eggs can run substantially higher depending on the characteristics of the supplier.
Bonilla's office said the bill did not
come up for a vote during today's Senate floor session but could come
up next Thursday.
come up for a vote during today's Senate floor session but could come
up next Thursday.
Posted in Stem Cells, Stem Cell Therapy
Comments Off on Pay-For-Eggs Legislation Draws More Media Attention
American Health Journal PBS Special Laminine Stem Cell Therapy Full Version – Video
Posted: June 20, 2013 at 1:41 am
American Health Journal PBS Special Laminine Stem Cell Therapy Full Version
http://www.LaminiNHealth.com/dc/ Doctors are interviewed about Fibroblast Growth Factor, Laminin, Cortisol, Serotonin Do-It-Yourself Stem Cell Therapy - La...
By: David Dolores
Read the original:
American Health Journal PBS Special Laminine Stem Cell Therapy Full Version - Video
Posted in Cell Therapy, Stem Cell Therapy
Comments Off on American Health Journal PBS Special Laminine Stem Cell Therapy Full Version – Video
International team submits IND application
Posted: June 19, 2013 at 4:10 pm
On 18 June 2013, there was an announcement at the Princess Margaret Cancer Centre, Toronto. There was also a post on the California stem cell agency blog entitled: Clinical trial to thwart cancer stem cells may begin soon. An excerpt from the post:
The Prince Margaret Center announced the FDA filing, called an Investigational New Drug application (IND), at an event in Toronto recognizing the private donors. A press release about the announcement was picked up at this biotech news site.
The Principal Investigators present for the announcement were Dr. Tak Mak of the Princess Margaret Cancer Centre and Dr. Dennis Slamon of the University of California, Los Angeles (UCLA). What they have done is summarized in another excerpt from the blog post:
By working first to understand the various proteins that drive cells to divide, particularly in cancer, they were able to pinpoint an enzyme, that if blocked, could be the key to keeping cancer in check. They then discovered that this enzyme, called PLK4, can be derailed by a new drug they developed. In the lab, it has been shown to inhibit the growth of breast, ovarian, colorectal, lung, pancreatic and prostate cancer, as well as melanoma.
Information about the human PLK4 protein is available here.
Some background: In June 2008, it was announced that a partnership had been formed between Canada’s Cancer Stem Cell Consortium (CSCC) and the California Institute for Regenerative Medicine (CIRM) for international collaboration to advance cancer stem cell research. An excerpt from the CSCC's announcement:
It is proposed that one of the first initiatives to be launched by the CSCC will be a collaboration between Canadian and Californian scientists through CIRM's upcoming Disease Team Research Awards Competition, which will support multi-disciplinary teams of scientists in pursuit of therapies for specific diseases.The goal is to fund teams that will develop therapy or diagnostics for a particular disease or serious injury.Successful proposals will likely include a description of a path to an Investigational New Drug filing at the end of the four-to-five year grant.
Note the intent to file an IND by the end of the term of the grant.
The results of the Disease Team Research Awards Competition were announced on October 28, 2009. The award to Drs. Slamon and Mak is Grant number DR1-01477. See: Therapeutic Opportunities to Target Tumor Initiating Cells in Solid Tumors. As was stated in a page about Cancer Stem Cells on the website of the Canadian Institutes for Health Research (CIHR), this award was to one of two multi-disciplinary research teams co-led by Canadian and Californian scientists. The other team is co-led by Dr. John Dick of the University Health Network and Dr. Dennis Carson of the University of California, San Diego. My blog post (October 29, 2009) about the awards is entitled: Disease Team awards announced. The post ends with this Disclosure:
I'm a member of the Board of the CSCC, but also a staff member (emeritus) at the University Health Network. So, I was in conflict of interest, and was absent during all of the discussions, by the CSCC Board, about which Canadian applications should be considered for the Disease Team awards.
Source:
http://cancerstemcellnews.blogspot.com/2013/06/international-team-submits-ind.html
Posted in Stem Cells, Stem Cell Therapy
Comments Off on International team submits IND application
ASCI Two Worlds of Stem Cell Therapy Animation – Video
Posted: June 18, 2013 at 8:41 pm
ASCI Two Worlds of Stem Cell Therapy Animation
Asian Stem Cell Institute (ASCI) Two Worlds of Stem Cell Therapy Animation Autologous Stem cell Treatments, mobilized peripheral blood, bone marrow and adipo...
By: stemcellregeneration
See the article here:
ASCI Two Worlds of Stem Cell Therapy Animation - Video
Posted in Stem Cell Therapy
Comments Off on ASCI Two Worlds of Stem Cell Therapy Animation – Video
Wellington Chen, M.D. of Advanced Rejuvenation Introduces Stem Cell Therapy For OsteoArthritis & COPD in Sarasota …
Posted: June 18, 2013 at 8:41 pm
Sarasota, Florida (PRWEB) June 18, 2013
After almost 20 years of performing regenerative treatments in the field of non surgical orthopedics, Wellington Chen, M.D., will begin conducting clinical trials for many degenerative diseases using adipose-derived stem cell therapy in Sarasota, Florida. The independent review board of the International cell medicine society is responsible for overseeing these trials.
Advanced Rejuvenation will treat patients suffering from chronic obstructive pulmonary disease (COPD) and osteoarthritis following the IRB-approved protocols. Advanced Rejuvenation will be using adult autologous stem cells, harvested from the patients own adipose (fat) tissue or bone marrow if fat is not available. Because patients are receiving their own cells, there is no risk of rejection. As of 2007, over 9,000 studies have shown the safety using these cell lines.
Autologous stem cell therapy are your bodies repair men. They are circulated throughout your body and as soon as there is a need for them, chemical messages trigger them to migrate to the area and do their magic. They are both immune modulating and also regenerative which makes them a great therapeutic agent for osteoarthritis and COPD. Numerous studies have shown them to have the capacity to grow new cartilage, muscle, ligaments, glands and even organs. We believe stem cell treatments will become the future of care for most orthopedic problems avoiding the need for surgery. With COPD, when stem cells are run into the blood stream through an IV they will mostly pass through the lungs. We are excited to be apart of these research studies.
Advanced Rejuvenation trained under scientist Kristin Comella, CEO of Stemlogix. She was recently named in the Wall Street Journal as one of the 50 most influential people on stem cell research. Advanced Rejuvenation will implement Stemlogixs patented extraction process, allowing for an exceptionally high yield and viability of stem cells from fat.
During the in-office and same day procedure, a mini liposuction is performed. A half of a cup of fat in harvested from around the abdominal region which produces approximately 8 million stem cells. The stem cells are isolated put back into the patients joints or with COPD via an IV infusion. Local anesthesia is all that is needed and pain medication can be prescribed but is rarely necessary.
Advanced Rejuvenation has treated various orthopedic conditions for 4 years using fat transfer and now offers these treatments to patients ranging from NFL players to retired golfers. If you would like more information, e-mail Advanced Rejuveantion at AskDrGecko(at)Gmail(dot)com or call our office.
About Advanced Rejuvenation
Advanced Rejuvenation is a multi specialty practice in Sarasota, Florida, specializing in regenerative treatments such as Stem Cell Treatments, Prolotherapy, Ozone Therapy, Naturopathic, Acupuncture, Chiropractic Functional Neurology, Osteopathy, Functional Medicine, Active Isolated Stretching (AIS)
Contact: Advanced Rejuvenation Phone: (941) 330-8553 E-mail: AskDrGecko(at)Gmail(dot)com Website: http://www.SarasotaStemCell.com Office address: 2033 Wood Street #210 Sarasota, Florida 34237
Continue reading here:
Wellington Chen, M.D. of Advanced Rejuvenation Introduces Stem Cell Therapy For OsteoArthritis & COPD in Sarasota ...
Posted in Stem Cell Therapy
Comments Off on Wellington Chen, M.D. of Advanced Rejuvenation Introduces Stem Cell Therapy For OsteoArthritis & COPD in Sarasota …
Wellington Chen, M.D. of Advanced Rejuvenation Introduces Stem Cell Therapy For OsteoArthritis & COPD in Sarasota …
Posted: June 18, 2013 at 10:42 am
Sarasota, Florida (PRWEB) June 18, 2013
After almost 20 years of performing regenerative treatments in the field of non surgical orthopedics, Wellington Chen, M.D., will begin conducting clinical trials for many degenerative diseases using adipose-derived stem cell therapy in Sarasota, Florida. The independent review board of the International cell medicine society is responsible for overseeing these trials.
Advanced Rejuvenation will treat patients suffering from chronic obstructive pulmonary disease (COPD) and osteoarthritis following the IRB-approved protocols. Advanced Rejuvenation will be using adult autologous stem cells, harvested from the patients own adipose (fat) tissue or bone marrow if fat is not available. Because patients are receiving their own cells, there is no risk of rejection. As of 2007, over 9,000 studies have shown the safety using these cell lines.
Autologous stem cell therapy are your bodies repair men. They are circulated throughout your body and as soon as there is a need for them, chemical messages trigger them to migrate to the area and do their magic. They are both immune modulating and also regenerative which makes them a great therapeutic agent for osteoarthritis and COPD. Numerous studies have shown them to have the capacity to grow new cartilage, muscle, ligaments, glands and even organs. We believe stem cell treatments will become the future of care for most orthopedic problems avoiding the need for surgery. With COPD, when stem cells are run into the blood stream through an IV they will mostly pass through the lungs. We are excited to be apart of these research studies.
Advanced Rejuvenation trained under scientist Kristin Comella, CEO of Stemlogix. She was recently named in the Wall Street Journal as one of the 50 most influential people on stem cell research. Advanced Rejuvenation will implement Stemlogixs patented extraction process, allowing for an exceptionally high yield and viability of stem cells from fat.
During the in-office and same day procedure, a mini liposuction is performed. A half of a cup of fat in harvested from around the abdominal region which produces approximately 8 million stem cells. The stem cells are isolated put back into the patients joints or with COPD via an IV infusion. Local anesthesia is all that is needed and pain medication can be prescribed but is rarely necessary.
Advanced Rejuvenation has treated various orthopedic conditions for 4 years using fat transfer and now offers these treatments to patients ranging from NFL players to retired golfers. If you would like more information, e-mail Advanced Rejuveantion at AskDrGecko(at)Gmail(dot)com or call our office.
About Advanced Rejuvenation
Advanced Rejuvenation is a multi specialty practice in Sarasota, Florida, specializing in regenerative treatments such as Stem Cell Treatments, Prolotherapy, Ozone Therapy, Naturopathic, Acupuncture, Chiropractic Functional Neurology, Osteopathy, Functional Medicine, Active Isolated Stretching (AIS)
Contact: Advanced Rejuvenation Phone: (941) 330-8553 E-mail: AskDrGecko(at)Gmail(dot)com Website: http://www.SarasotaStemCell.com Office address: 2033 Wood Street #210 Sarasota, Florida 34237
Excerpt from:
Wellington Chen, M.D. of Advanced Rejuvenation Introduces Stem Cell Therapy For OsteoArthritis & COPD in Sarasota ...
Posted in Stem Cell Therapy
Comments Off on Wellington Chen, M.D. of Advanced Rejuvenation Introduces Stem Cell Therapy For OsteoArthritis & COPD in Sarasota …
Stemlogix Stem Cell Therapy Heals Angie the Chimp! – Video
Posted: June 16, 2013 at 11:41 am
Stemlogix Stem Cell Therapy Heals Angie the Chimp!
A year ago Stemlogix donated its stem cell technology to veterinarians in Florida to treat a rescue chimpanzee at the "Save The Chimps" facility named Angie. Angie was suffering from an ACL...
By: Stemlogix, LLC
Read the original here:
Stemlogix Stem Cell Therapy Heals Angie the Chimp! - Video
Posted in Stem Cell Therapy
Comments Off on Stemlogix Stem Cell Therapy Heals Angie the Chimp! – Video
Compensation for Human Eggs Approved by Key California Senate Committee, But Not For CIRM Researchers
Posted: June 16, 2013 at 2:58 am
Legislation that would permit women in
California to be paid for their eggs for scientific research
yesterday cleared a key state Senate committee and is likely headed
for the governor's desk.
California to be paid for their eggs for scientific research
yesterday cleared a key state Senate committee and is likely headed
for the governor's desk.
The measure by Assemblywoman Susan
Bonilla, D-Concord, was approved on a 6-1 vote by the Senate Health
Committee and now goes to the Senate floor. Earlier, it passed the
Assembly on a 54-20 vote.
Bonilla, D-Concord, was approved on a 6-1 vote by the Senate Health
Committee and now goes to the Senate floor. Earlier, it passed the
Assembly on a 54-20 vote.
Some stem cell researchers and other
scientists have chafed under state restrictions that bar compensation
for eggs while that the same time fertility clinics are paying an average of $9,000 a session for eggs, with some prices going as high as $50,000.
scientists have chafed under state restrictions that bar compensation
for eggs while that the same time fertility clinics are paying an average of $9,000 a session for eggs, with some prices going as high as $50,000.
However, the legislation will not
affect researchers using grants from the $3 billion California stem
cell agency. The agency's regulations bar compensation for eggs in
the research that it funds. That means that at least a two-tiered
research system would exist in California not to mention another tier
created by federal regulations that differ from both those of the
stem cell agency and those set by the legislation.
affect researchers using grants from the $3 billion California stem
cell agency. The agency's regulations bar compensation for eggs in
the research that it funds. That means that at least a two-tiered
research system would exist in California not to mention another tier
created by federal regulations that differ from both those of the
stem cell agency and those set by the legislation.
CIRM's restrictions are required by
Proposition 71, which created the agency in 2004, and cannot be
changed without a 70 percent vote of the legislature. Bonilla's bill
requires only a majority vote.
Proposition 71, which created the agency in 2004, and cannot be
changed without a 70 percent vote of the legislature. Bonilla's bill
requires only a majority vote.
Bonilla's legislation is sponsored by
American Society for Reproductive Medicine, the chief industry
group for the largely unregulated fertility industry.
American Society for Reproductive Medicine, the chief industry
group for the largely unregulated fertility industry.
The analysis prepared for yesterday's
committee session summarized Bonilla's arguments for the measure in
this fashion:
committee session summarized Bonilla's arguments for the measure in
this fashion:
“This bill seeks to create equity in
the field of medical research compensation by removing the
prohibition on compensation for women participating in oocyte (egg)
donation for medical research. All other research subjects are
compensated for their time, trouble, and inconvenience involved in
participating in research. AB 926 ensures that women are treated
equally to all other research subjects - allowing them to actively
evaluate their participation in research studies. Unfortunately, the
ban on compensation has had serious unintended consequences. It has
led to a de facto prohibition on women’s reproductive research in
California, adversely impacting the same women that the ban intended
to protect. With few oocytes donated, fertility research and
fertility preservation research has been at a standstill. This
greatly affects women suffering from fertility issues and women
facing cancer who would like to preserve their oocytes.”
A number of organizations are opposed
to the bill including the Center for Genetics and Society in Berkeley
and the Catholic Church. The bill analysis summarized some of the
opposition arguments in this fashion:
to the bill including the Center for Genetics and Society in Berkeley
and the Catholic Church. The bill analysis summarized some of the
opposition arguments in this fashion:
“Egg harvesting exposes healthy young
women to multiple synthetic hormones in order to produce many times
the normal number of eggs per cycle. One of the potential harms is
OHSS, which has resulted in hospitalizations and at least a few
documented deaths. These groups state that many experts remain
concerned about the long-term risks of these drugs, especially
their potential impact on infertility and various cancers.
Follow-up research on egg providers, which could establish the
frequency and severity of these adverse outcomes, is widely
recognized to be grossly inadequate.”
In addition to risk and religious
objections, opponents also argue that poor and minority women are
likely to be exploited by enterprises seeking their eggs to resell at
a profit.
objections, opponents also argue that poor and minority women are
likely to be exploited by enterprises seeking their eggs to resell at
a profit.
No major stem cell research
organizations, including the California stem cell agency, have taken
a position on the bill. The legislation has received little public
attention, although The Sacramento Bee carried an article last March.
Ruha Benjamin, author of "People's Science" and assistant professor at Boston
University, also wrote about the measure in April on the Huffington
Post. Benjamin said,
organizations, including the California stem cell agency, have taken
a position on the bill. The legislation has received little public
attention, although The Sacramento Bee carried an article last March.
Ruha Benjamin, author of "People's Science" and assistant professor at Boston
University, also wrote about the measure in April on the Huffington
Post. Benjamin said,
“UC Berkeley professor Charis
Thompson compares egg
donation to 'other kinds of physically demanding service work,'
arguing for a 'salary negotiation between the state agency (or
relevant employer) and the donor.' This, she contends, is a 'sensible
and dignified recognition of [the donor's] work, time, and effort.'
And instead of refusing compensation to women, Thompson suggests that
we 'direct our efforts to understanding and minimizing' the risks.
Thompson compares egg
donation to 'other kinds of physically demanding service work,'
arguing for a 'salary negotiation between the state agency (or
relevant employer) and the donor.' This, she contends, is a 'sensible
and dignified recognition of [the donor's] work, time, and effort.'
And instead of refusing compensation to women, Thompson suggests that
we 'direct our efforts to understanding and minimizing' the risks.
“Indeed. Now more than ever, we must
redouble our efforts, because the market in eggs appears to be
expanding from private reproduction to public research, and
increasingly overseas, if the surrogacy
industry is any indication of how 'cheaper' women become a
reserve army of bio-labor in less regulated regions.”
redouble our efforts, because the market in eggs appears to be
expanding from private reproduction to public research, and
increasingly overseas, if the surrogacy
industry is any indication of how 'cheaper' women become a
reserve army of bio-labor in less regulated regions.”
Posted in Stem Cells, Stem Cell Therapy
Comments Off on Compensation for Human Eggs Approved by Key California Senate Committee, But Not For CIRM Researchers
Merksamer Makes Only Bid For Stem Cell Agency Lobbying Contract
Posted: June 16, 2013 at 2:58 am
Only one of California's lobbying firms
is interested in working for the California stem cell agency – at
least interested enough to put in a bid.
is interested in working for the California stem cell agency – at
least interested enough to put in a bid.
However, that is likely more of a
function of the small size of the contract – $65,000 – and the
entrenched nature of CIRM's existing lobbyist – Nielsen, Merksamer,
Parrinello, Gross & Leoni LLP – one of the state Capitol's
larger lobbying firms with $5 million in billings last year.
function of the small size of the contract – $65,000 – and the
entrenched nature of CIRM's existing lobbyist – Nielsen, Merksamer,
Parrinello, Gross & Leoni LLP – one of the state Capitol's
larger lobbying firms with $5 million in billings last year.
The firm touted its longstanding
connection to the $3 billion agency in its 21-page proposal in
response to a CIRM RFA this spring. The firm has been with CIRM since
2005.
connection to the $3 billion agency in its 21-page proposal in
response to a CIRM RFA this spring. The firm has been with CIRM since
2005.
Nielsen Merksamer's proposal also noted
a couple of other interesting aspects of the continuing arrangement.
CIRM will run out of money for new grants in 2017, and Nielsen
Merkasamer said,
a couple of other interesting aspects of the continuing arrangement.
CIRM will run out of money for new grants in 2017, and Nielsen
Merkasamer said,
“Furthermore, as a premier
legislative advocacy and (Nielsen's italics) ballot measure
law ?rm, Nielsen Merksamer can actively and effectively assist CIRM
as it contemplates returning to the voters for additional funding.”
The proposal also suggested that it can
conceal information that normally would be public record. The firm
said,
conceal information that normally would be public record. The firm
said,
“Another unique advantage offered by
Nielsen Merksamer is that, unlike the vast majority of lobbying ?rms,
since we are a full-service law ?rm, our relationships with our
clients are subject to the attorney-client privilege.”
CIRM used such a technique in 2012 and 2008 in matters involving its budget and PR advice.
Nielsen Merksamer also said,
“(N)o one understands CIRM’s 'total
picture' better than Nielsen Merksamer. Not only has Nielsen
Merksamer been representing CIRM before the Legislature for the past
decade, but Nielsen Merksamer was also one of the principal drafters
of the aforementioned Proposition 71—which brought CIRM to life.
The depth of Nielsen Merksamer’s familiarity with, and
understanding of, CIRM’s mission and structure, the challenges it
faces, and the promise it holds simply cannot be matched by any other
legislative advocate.”
The firm said it would not need the
$65,000 offered by CIRM but would charge only $49,200 annually, about the same as
it has been paid for several years. Steve Merksamer and Gene Erbin,
who drafted portions of Proposition 71, would handle most of CIRM's
affairs. John Moffatt and Missy Johnson would also be available.
$65,000 offered by CIRM but would charge only $49,200 annually, about the same as
it has been paid for several years. Steve Merksamer and Gene Erbin,
who drafted portions of Proposition 71, would handle most of CIRM's
affairs. John Moffatt and Missy Johnson would also be available.
The firm's proposal outlined several
instances where it successfully killed legislation opposed by CIRM.
You can read about them in their proposal below.
instances where it successfully killed legislation opposed by CIRM.
You can read about them in their proposal below.
Posted in Stem Cells, Stem Cell Therapy
Comments Off on Merksamer Makes Only Bid For Stem Cell Agency Lobbying Contract